Filing Flows › Guardian Pharmacy Services (GRDN) › Q2 2026
Guardian Pharmacy Services (GRDN) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Guardian Pharmacy Services (GRDN) reported revenue of $352M for the second quarter 2026 (Q2 2026), +2% from a year earlier and +5% from the quarter before. Operating margin was 5.9%, net earnings $22.1M (6.3% of revenue).
Guardian Pharmacy Services, Q2 2026: revenue $352M (+2% year over year), operating margin 5.9%, net earnings $22.1M, operating cash flow $30.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $352M | +5% | +2% |
| Gross profit | $80.0M | +5% | +17% |
| Operating profit | $20.6M | +17% | +64% |
| Net earnings | $22.1M | +63% | +151% |
| Operating cash flow | $30.0M | +395% | +51% |
What changed
Revenue was $351.8M in Q2 2026, up 2% year over year and up 5% from the previous quarter.
Gross margin was 22.8%, up 3.0 points from Q2 2025. Operating profit was $20.6M, a 5.9% margin (up 2.2 points year over year). Of the extra revenue versus Q2 2025, 108% reached operating profit, above the 4% margin then. Operating expenses grew 7% against revenue growth of 2%. Net earnings were $21.9M, up 142% year over year. The effective tax rate was 25.7%. Non-operating items added $9.1M, 31% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $30.0M (up 51% year over year), 136% of net earnings. Non-cash charges added back $5.8M of depreciation and amortization and $2.9M of share-based compensation.
Questions
What was Guardian Pharmacy Services' revenue in the second quarter 2026?
Guardian Pharmacy Services (GRDN) reported revenue of $352M for the second quarter 2026 (Q2 2026), +2% from a year earlier and +5% from the quarter before.
Was Guardian Pharmacy Services profitable in the second quarter 2026?
Operating profit was $20.6M (5.9% of revenue) and net earnings $22.1M.